Publication
Road to COP29: Our insights
The 28th Conference of the Parties on Climate Change (COP28) took place on November 30 - December 12 in Dubai.
Australia | Publication | December 2019
When it comes to questions of reputation in the workplace, the shadow of the Hayne Royal Commission hangs heavy over major Australian organisations.
In the year of Hayne’s landmark report on the conduct of Australian financial institutions, measuring, assessing and improving workplace culture has taken on new urgency and heightened feelings of exposure to reputational risk issues.
Norton Rose Fulbright surveyed 132 leaders across business and government between August and September 2019 to further its understanding of what reputational risk means to today’s organisations. The results of this research, taken together with the views gathered in our inaugural Reputational Risk Australia report in 2017, are detailed in this report.
The results clearly show a growing intensity of concern about workplace reputational issues. Major organisations are becoming both more sensitive to reputational risk and more willing to identify its key drivers.
To find out more about what reputational risk means to Australian organisations and benchmark your business against your peers, read our full report.
For more information, contact one of our employment and labour and risk advisory experts below.
Publication
The 28th Conference of the Parties on Climate Change (COP28) took place on November 30 - December 12 in Dubai.
Publication
Africa faces a stark reality: contributing less than 4% of global greenhouse gas emissions, the continent is disproportionately impacted by climate change, threatening its development and stability.
Publication
Miranda Cole, Julien Haverals and Emma Clarke of our Brussels/ London offices are the authors of a chapter on procedural issues in merger control that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences. This covers a number of significant procedural developments that have affected merger review of life sciences transactions.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023